Trends in Chronic Pain and Its Management Among Nursing Home Residents With Dementia
A team of investigators evaluated numerous factors associated with the management of pain among residents of nursing homes with dementia.
A team of investigators evaluated numerous factors associated with the management of pain among residents of nursing homes with dementia.
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
Researchers sought to evaluate differences in immunologic markers between those with HIV and those at risk for HIV with opioid use disorder.
Retrospective chart review shows health disparities in acute pain management among racial/ethnic minority patients and women in an emergency department.
Opiate prescriptions predicted by primary care physician specialty and patient age, gender, race.
A 45-year-old man presents to his primary care office at 9:00 AM after he was asked to leave work the day before because he smelled of alcohol and had been acting erratically.
The number of US health care providers certified to prescribe buprenorphine more than doubled in the past 4 years, and treatment advocates hope to see that trend continue.
If approved, the OTC nasal spray would deliver 4 mg of naloxone per spray.
The 2022 CDC Clinical Practice Guideline is intended to help clinicians weigh the benefits and risks of opioids and alternative pain treatments for outpatients.
Jim Anderson, MPAS, PA-C, wonders if SAMHSA will make the methadone take-home flexibility program permanent.